FUJIFILM India has announced the launch of its FW500 Clinical Chemistry Analyzer, marking a significant expansion in its diagnostics and in-vitro diagnostics (IVD) portfolio. The new system is designed to deliver high accuracy, reliability, and speed in clinical testing, supporting laboratories and hospitals in enhancing diagnostic efficiency across India.

The FW500 analyzer combines advanced Japanese technology with a compact and user-friendly design, catering to both mid- and large-sized laboratories. It offers a high throughput rate, enabling faster analysis of biochemical parameters essential for disease screening, diagnosis, and monitoring.

According to the company, the new analyzer aligns with FUJIFILM’s commitment to Never Stop Innovating for a Healthier World”, reinforcing its focus on strengthening India’s healthcare infrastructure through innovative diagnostic solutions.

Koji Wada, Managing Director of FUJIFILM India, stated, “With the launch of the FW500, we are furthering our mission to make cutting-edge diagnostic technologies accessible to healthcare providers across India. This innovation will support clinicians in delivering precise and timely patient care.”

The company has been steadily expanding its presence in the diagnostics and life sciences segment, offering a wide range of products including clinical chemistry, immunoassay, and point-of-care testing systems. The introduction of the FW500 further strengthens FUJIFILM’s portfolio in the rapidly growing diagnostics market in India, which is seeing increased demand for *automation and accuracy in laboratory medicine.

With this launch, FUJIFILM India aims to empower healthcare institutions with reliable and efficient diagnostic tools, supporting the country’s vision of accessible, affordable, and quality healthcare for all